Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement
JACC: Cardiovascular Interventions · 2026-03 · 19 (6) · 680-693
DOI: 10.1016/j.jcin.2026.01.281 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026-03. Verfasst von Andrea Scotti und 46 weiteren Autor:innen. Beteiligte Einrichtung: Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA; Departm…. Hauptthemen laut MEDLINE: Cardiac Catheterization, Heart Valve Prosthesis Implantation, Tricuspid Valve, Tricuspid Valve Insufficiency. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The clinical efficacy of transcatheter tricuspid valve replacement (TTVR) in abolishing tricuspid regurgitation might be attenuated by the occurrence of paravalvular leak (PVL). OBJECTIVES: The aim of this study was to investigate the incidence, outcomes, and predictors of moderate or severe PVL post-TTVR. METHODS: All eligible patients undergoing TTVR in the multicenter TRIPLACE (Global Multicenter Registry on Transcatheter Tricuspid Valve Replacement) registry were stratified according to predischarge PVL severity. The primary endpoint was the occurrence of moderate or severe PVL post-TTVR. Secondary endpoints were 1-year mortality, 1-year heart failure hospitalization, and post-TTVR NYHA functional class III or IV. Outcomes were analyzed using logistic regression (PVL), Cox regression (mortality), and Gray's test (heart failure). RESULTS: Of 394 TTVR patients, 24 (6.1%) had moderate or severe, 88 (22.3%) mild, and 282 (71.6%) no or trace PVL post-TTVR. Patients with moderate or severe PVL had significantly higher TRI-SCOREs (P < 0.001), lower estimated glomerular filtration rates (P = 0.001), and larger right ventricular and right atrial dimensions (P = 0.002 for both). Patients with moderate or severe PVL post-TTVR had worse 1-month functional class (53% in NYHA functional class III or IV) than those with mild (16%) or no or trace (15%) PVL. The presence of moderate or severe PVL post-TTVR was associated with increased 1-year mortality (39.7%; adjusted HR: 2.6; 95% CI: 1.2-5.7) compared with those with mild (12.6%) or no or trace (10.5%) PVL. A larger right atrial volume (P = 0.02), device malposition (P = 0.0002), and type IV valve morphology (P = 0.01) were independently associated with moderate or severe PVL post-TTVR. CONCLUSIONS: Moderate or greater PVL occurred in 6.1% of patients post-TTVR and was associated with increased 1-year mortality and worse functional status. A larger right atrial volume, device malposition, and type IV valve morphology conferred a higher risk for developing moderate or severe PVL post-TTVR. These findings have important implications for future TTVR design and procedural optimization. (Global Multicenter Registry on Transcatheter Tricuspid Valve Replacement [TRIPLACE]; NCT06033274).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA; Department of Cardiology, University Hospital of Salamanca, IBSAL, Salamanca,…
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: alatib@gmail.com.
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
- Oregon Health and Science University, Portland, Oregon, USA.
- Centre for Heart Valve Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
- Division of Cardiology, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, New York, USA.
Zitieren
APA
Scotti, A., Latib, A., Filtz, A., Sturla, M., Zahr, F., Boone, R., Kodali, S., Tchétché, D., De Backer, O., Coisne, A., Ludwig, S., Garcia, S. A., Stolz, L., Loureiro, R. E., Adam, M., De Marco, F., Ho, E. C., Cheung, A., Biroli, M., …, & Puri, R. (2026). Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement. JACC: Cardiovascular Interventions, 19(6), 680-693. https://doi.org/10.1016/j.jcin.2026.01.281
Vancouver
Scotti A, Latib A, Filtz A, Sturla M, Zahr F, Boone R, et al. Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement. JACC: Cardiovascular Interventions. 2026;19(6):680-693. doi:10.1016/j.jcin.2026.01.281
BibTeX
@article{Scotti2026,
author = {Scotti, Andrea and Latib, Azeem and Filtz, Annalisa and Sturla, Matteo and Zahr, Firas and Boone, Robert and Kodali, Susheel and Tchétché, Didier and De Backer, Ole and Coisne, Augustin and Ludwig, Sebastian and Garcia, Santiago A and Stolz, Lukas and Loureiro, Rodrigo Estevez and Adam, Matti and De Marco, Federico and Ho, Edwin C and Cheung, Anson and Biroli, Matteo and Patrascu, Alexandru and Alnasser, Sami and Chadderdon, Scott and Lulic, Davorka and Bartkowiak, Joanna and Echarte-Morales, Julio and Sievert, Horst and Byrne, Timothy and Maisano, Francesco and Frerker, Christian and Dumonteil, Nicolas and Oliva, Omar A and Rudolph, Tanja K and Rudolph, Felix and Guddeti, Raviteja and Bakhtadze, Beka and Krishnaswamy, Amar and Kapadia, Samir R and Portillo, Juan Del and Rodés-Cabau, Josep and Schofer, Niklas and Cruz-Gonzalez, Ignacio and Granada, Juan and Hausleiter, Jörg and Hahn, Rebecca T and Modine, Thomas and Fam, Neil and Puri, Rishi},
title = {Incidence, Clinical Implications, and Predictors of Paravalvular Leak Following Transcatheter Tricuspid Valve Replacement},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {6},
pages = {680--693},
doi = {10.1016/j.jcin.2026.01.281}
}
EUVIMED